Pfizer's next-gen pneumonia shot beats Prevnar 20; Relay targets $175M

morningstar.com·May 20, 2026 · 7 h fa

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

statnews.com·May 19, 2026 · 1 g fa

A new ranking of pharma companies by R&D performance

fiercepharma.com·May 18, 2026 · 2 g fa

Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals

biopharmadive.com·May 20, 2026 · 16 h fa

Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update

biopharmadive.com·May 19, 2026 · 1 g fa

Relay drug shows early promise against rare blood vessel diseases

fiercepharma.com·May 15, 2026 · 5 g fa

Eisai's slow push toward blockbuster Leqembi sales gains steam with $900M forecast

smh.com.au·May 19, 2026 · 1 g fa

Amplia takes aim at billion-dollar pancreatic cancer drug market